Comment on

• New insights into the diagnostic accuracy of complexed and total prostate specific antigen using discordance analysis characteristics.

  Jung K, Lein M, Butz H, Stephan C, Loening SA, Keller T. Jung K, et al. J Urol. 2006 Apr;175(4):1275-80. doi: 10.1016/S0022-5347(05)00707-X. J Urol. 2006. PMID: 16515979
• Prostate cancer detection among men with prostate specific antigen levels of 2.5 to 4.0 ng/ml in a Japanese urological referral population.

  Kobayashi T, Mitsumori K, Kawahara T, Nishizawa K, Ogura K, Ide Y. Kobayashi T, et al. J Urol. 2006 Apr;175(4):1281-5. doi: 10.1016/S0022-5347(05)00694-4. J Urol. 2006. PMID: 16515980
• Prostate specific antigen changes as related to the initial prostate specific antigen: data from the prostate, lung, colorectal and ovarian cancer screening trial.

  Crawford ED, Pinsky PF, Chia D, Kramer BS, Fagerstrom RM, Andriole G, Reding D, Gelmann EP, Levin DL, Gohagan JK. Crawford ED, et al. J Urol. 2006 Apr;175(4):1286-90; discussion 1290. doi: 10.1016/S0022-5347(05)00706-8. J Urol. 2006. PMID: 16515981 Clinical Trial.
• A novel serum marker, total prostate secretory protein of 94 amino acids, improves prostate cancer detection and helps identify high grade cancers at diagnosis.

  Nam RK, Reeves JR, Toi A, Dulude H, Trachtenberg J, Emami M, Daigneault L, Panchal C, Sugar L, Jewett MA, Narod SA. Nam RK, et al. J Urol. 2006 Apr;175(4):1291-7. doi: 10.1016/S0022-5347(05)00695-6. J Urol. 2006. PMID: 16515983